Implanet Financials
| ALIMP Stock | EUR 0.11 0.01 8.33% |
Implanet |
Understanding current and past Implanet Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Implanet's financial statements are interrelated, with each one affecting the others. For example, an increase in Implanet's assets may result in an increase in income on the income statement.
Implanet Stock Summary
Implanet competes with Gensight Biologics, Innate Pharma, Poxel SA, and Nanobiotix. Implanet S.A. provides various spine, knee, and arthroscopy orthopedic implants in France, the United States, Brazil, and internationally. Implanet S.A. was founded in 2006 and is based in Martillac, France. IMPLANET operates under Medical Devices classification in France and is traded on Paris Stock Exchange. It employs 45 people.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR0013470168 |
| Business Address | Technopole Bordeaux Montesquieu, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.implanet.com |
| Phone | 33 5 57 99 55 55 |
| Currency | EUR - Euro |
You should never invest in Implanet without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Implanet Stock, because this is throwing your money away. Analyzing the key information contained in Implanet's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Implanet Key Financial Ratios
Implanet's financial ratios allow both analysts and investors to convert raw data from Implanet's financial statements into concise, actionable information that can be used to evaluate the performance of Implanet over time and compare it to other companies across industries.Implanet Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Implanet's current stock value. Our valuation model uses many indicators to compare Implanet value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Implanet competition to find correlations between indicators driving Implanet's intrinsic value. More Info.Implanet SA is rated fourth in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Implanet's earnings, one of the primary drivers of an investment's value.Implanet SA Systematic Risk
Implanet's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Implanet volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Implanet SA correlated with the market. If Beta is less than 0 Implanet generally moves in the opposite direction as compared to the market. If Implanet Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Implanet SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Implanet is generally in the same direction as the market. If Beta > 1 Implanet moves generally in the same direction as, but more than the movement of the benchmark.
Implanet December 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Implanet help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Implanet SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Implanet SA based on widely used predictive technical indicators. In general, we focus on analyzing Implanet Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Implanet's daily price indicators and compare them against related drivers.
| Downside Deviation | 8.26 | |||
| Information Ratio | (0.0002) | |||
| Maximum Drawdown | 26.52 | |||
| Value At Risk | (7.69) | |||
| Potential Upside | 8.33 |
Additional Tools for Implanet Stock Analysis
When running Implanet's price analysis, check to measure Implanet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Implanet is operating at the current time. Most of Implanet's value examination focuses on studying past and present price action to predict the probability of Implanet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Implanet's price. Additionally, you may evaluate how the addition of Implanet to your portfolios can decrease your overall portfolio volatility.